News
New study identifies two proteins that may contribute to stroke recurrence
The study discovered genetic markers in inflammation that may be related to a second stroke or other major cardiovascular event following a stroke. These findings could help identify drug targets to mitigate stroke-related disability and mortality. People who experience an arterial ischemic stroke (AIS) or transient ischemic…
Three new projects funded by Bristol BRC Director’s Fund
Three new research projects have secured funding from the National Institute for Health and Care Research (NIHR) Bristol Biomedical Research Centre’s (Bristol BRC) Director’s fund. The Director’s Fund supports exciting new projects across all our research themes which we hope will be developed into something that could directly benefit patients.
PhD opportunity with Bristol BRC and Health Data Research UK
The NIHR Bristol Biomedical Research Centre is working with Health Data Research UK (HDR UK) to offer a place on their prestigious Big Data for Complex Diseases PhD programme. HDR UK is funding six PhDs with leading UK universities and research organisations. Within this…
Forecasting long-term demand in emergency departments
Policies designed to improve both health-related behaviours and personal circumstances could reduce the number of people attending emergency departments (ED) and improve the quality and safety of care in the long-term. Researchers from Bristol’s BRC combined statistical models looking at population health and health service capacity to predict monthly ED…
Pfizer-BioNTech and AstraZeneca vaccines offer high protection against severe COVID-19, 6 months after second doses, finds study of over 7 million adults
Protection against severe COVID-19 by two doses of Pfizer-BioNTech and AstraZeneca COVID-19 vaccines remained high up to six months after second doses, finds new research which analysed NHS health record data on over seven million adults. Reassuringly, the University of Bristol-led study published in The BMJ today [20 July],…
Cochrane review published on 1p19q detection in glioma
University of Bristol researchers have contributed to an NIHR funded update to the Cochrane review on 1p19q detection in glioma, which has just been published. Gliomas are a type of brain tumour (cancer). There are different types of glioma, with different changes in their genetic material. One of the…
Regular exercise reduces the risk of and death from pneumonia, study suggests
People who exercise regularly can reduce their risk of developing and dying from pneumonia, new research has found. The study, led by researcher the University of Bristol, and funded by the National Institute for Health Research, Bristol Biomedical Research Centre (NIHR Bristol BRC) analysed, for the first time, ten population…
Professor Jonathan Sterne presents to US Food and Drug Administration on COVID-19 boosters
Professor Jonathan Sterne, Deputy Director of the National Institute for Health Research Bristol Biomedical Research Centre (NIHR Bristol BRC), has presented evidence to the US Food and Drug Administration (FDA) on COVID-19 vaccination boosters today, Friday 17 September. The presentation is part of the FDA’s advisory committee meeting to discuss…
New population-wide health data resource to accelerate research on COVID-19 and cardiovascular disease in England
For the first time, a new linked health data resource covering 54.4 million people – over 96 per cent of the English population – is now available for researchers from across the UK to collaborate in NHS Digital’s secure research environment. This resource will enable vital research to take place…